These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 171722

  • 1. [2 cases of hemolytic complications during intermittent treatment with rifampicin].
    Năstase M, Brener E, Năstase R, Borgovan L.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(1):43-6. PubMed ID: 171722
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mild haemolysis associated with flu-syndrome during daily rifampicin treatment--a case report.
    Yeo CT, Wang YT, Poh SC.
    Singapore Med J; 1989 Apr; 30(2):215-6. PubMed ID: 2609182
    [Abstract] [Full Text] [Related]

  • 5. [Hematological abnormalities during treatment with rifampicin].
    Lebacq E, Taminau E.
    Lille Med; 1974 Mar; 19(3):269-71. PubMed ID: 4437277
    [No Abstract] [Full Text] [Related]

  • 6. [Immunological aspects of adverse reactions during treatment with rifampicin].
    Zeană C, Bănică D, Algeorge G.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981 Mar; 30(1):33-7. PubMed ID: 6264568
    [Abstract] [Full Text] [Related]

  • 7. Acute hemolytic anemia caused by irregular rifampicin therapy.
    Oğuz A, Kanra T, Gökalp A, Gültekin A.
    Turk J Pediatr; 1989 Mar; 31(1):83-8. PubMed ID: 2609438
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis.
    Luzzati R, Giacomazzi D, Franchi F, Barcobello M, Vento S.
    South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Specific features of acute renal failure in patients treated with rifampicin].
    Munteanu L, Golea O, Nicolicioiu M, Tudorache V.
    Pneumologia; 2002 Aug; 51(1):15-20. PubMed ID: 12043271
    [Abstract] [Full Text] [Related]

  • 18. [Presence of antibodies against rifampicin in patients under tuberculostatic treatment].
    Ion N, Jemma I, Sfetcu V.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981 Aug; 30(1):39-42. PubMed ID: 6264569
    [Abstract] [Full Text] [Related]

  • 19. [Recurrent renal failures in continuous treatment with rifampicin].
    Löllgen H, Bolte JP.
    Munch Med Wochenschr; 1973 May 18; 115(20):913-5. PubMed ID: 4740450
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.